Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial
Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating the study record is not accessible at this time. The layout includes a minimal header, a Home link, and a Revision banner, reflecting an error state rather than the usual study details.SummaryDifference17%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe revision tag on the page has been updated from v3.6.5 to v3.6.6. This indicates a minor backend/content update to the page rather than a change to study data or user-facing content.SummaryDifference0.1%

- Check56 days agoChange DetectedA new Revision: v3.6.5 label was added to the page and the previous Revision: v3.6.4 label was removed, updating the page's version identifier. This reflects an update to the site's software version rather than changes to study content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now displays Revision: v3.6.4 in place of the previous v3.6.3, indicating a backend/presentation update without changes to the listed study information.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a small update to the page's documentation/formatting rather than substantive content changes.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, indicating a new frontend build without changes to the study information or navigation.SummaryDifference0.1%

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.